Shugeng Gao
Chinese Academy of Medical Sciences & Peking Union Medical College · 293 works · 9,434 citations · h-index 44
Top works
- Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
- Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
- Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry
- Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
- Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non–Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel
- Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non–Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy
- Lung Cancer in People’s Republic of China
- Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysis
- A retrospective study of unicentric and multicentric Castleman’s disease: a report of 52 patients
- MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA
- Expert consensus on resection of chest wall tumors and chest wall reconstruction
- The Society for Translational Medicine: clinical practice guidelines for the postoperative management of chest tube for patients undergoing lobectomy
- Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers
- Survival Nomogram for Stage IB Non-Small-Cell Lung Cancer Patients, Based on the SEER Database and an External Validation Cohort
- Systemic immune‐inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non‐small cell lung cancer
- Tracheobronchial Adenoid Cystic Carcinoma: 50-Year Experience at the National Cancer Center, China
- Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases
- Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma
- The efficiency of 18F-FDG PET-CT for predicting the major pathologic response to the neoadjuvant PD-1 blockade in resectable non-small cell lung cancer
- A Matched Comparison Study of Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early-stage Nonsmall Cell Lung Cancer